{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:00:05Z","timestamp":1791406805830,"version":"4.3.3"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00284-026-04992-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:46:58Z","timestamp":1780418818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gut Microbiota and Autoimmune Diseases: The Therapeutic Potential of Probiotics"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6067-1074","authenticated-orcid":false,"given":"Angelika","family":"Domaga\u0142a","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3818-8972","authenticated-orcid":false,"given":"Aneta","family":"Kiecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"issue":"10","key":"4992_CR1","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1210\/jc.2019-00481","volume":"104","author":"J Ho","year":"2019","unstructured":"Ho J et al (2019) Effect of probiotic on microbiota, intestinal permeability, and glycemic control in children with type 1 diabetes. J Clin Endocrinol Metab 104(10):4427\u20134440","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4992_CR2","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1007\/s00125-007-0791-0","volume":"50","author":"PD Cani","year":"2007","unstructured":"Cani PD et al (2007) Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetology 50(11):2374\u20132383","journal-title":"Diabetology"},{"key":"4992_CR3","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.3390\/app13084726","volume":"13","author":"C Thoda","year":"2023","unstructured":"Thoda C, Touraki M (2023) Immunomodulatory properties of probiotics and their derived bioactive compounds. Appl Sci 13:4726","journal-title":"Appl Sci"},{"key":"4992_CR4","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature07336","volume":"455","author":"L Wen","year":"2008","unstructured":"Wen L et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455:1109\u20131113","journal-title":"Nature"},{"issue":"1","key":"4992_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/1756283X12459294","volume":"6","author":"P Hemarajata","year":"2013","unstructured":"Hemarajata P, Versalovic J (2013) Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Th Adv Gastroenterol 6(1):39\u201351","journal-title":"Th Adv Gastroenterol"},{"issue":"1","key":"4992_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1172\/JCI32639","volume":"118","author":"S Abdollahi-Roodsaz","year":"2008","unstructured":"Abdollahi-Roodsaz S et al (2008) Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest 118(1):205\u2013216","journal-title":"J Clin Invest"},{"key":"4992_CR7","first-page":"527696","volume":"015","author":"R Rogier","year":"2015","unstructured":"Rogier R, Koenders MI, Abdollahi-Roodsaz S (2015) Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis. J Immunol Res 015:527696","journal-title":"J Immunol Res"},{"issue":"11","key":"4992_CR8","doi-asserted-by":"publisher","first-page":"9171","DOI":"10.3390\/nu7115461","volume":"7","author":"ME Mej\u00eda-Le\u00f3n","year":"2015","unstructured":"Mej\u00eda-Le\u00f3n ME, Barca AM (2015) Diet, microbiota and immune system in type 1 diabetes development and evolution. Nutrients 7(11):9171\u20139184","journal-title":"Nutrients"},{"issue":"9","key":"4992_CR9","doi-asserted-by":"publisher","first-page":"e0137429","DOI":"10.1371\/journal.pone.0137429","volume":"10","author":"S Miyake","year":"2015","unstructured":"Miyake S et al (2015) Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV Clusters. PLoS ONE 10(9):e0137429","journal-title":"PLoS ONE"},{"issue":"2","key":"4992_CR10","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/01.MIB.0000200323.38139.c6","volume":"12","author":"H Sokol","year":"2006","unstructured":"Sokol H et al (2006) Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 12(2):106\u2013111","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"4992_CR11","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S1474-4422(19)30356-4","volume":"19","author":"JF Cryan","year":"2020","unstructured":"Cryan JF et al (2020) The gut microbiome in neurological disorders. Lancet Neurol 19(2):179\u2013194","journal-title":"Lancet Neurol"},{"issue":"3","key":"4992_CR12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jhepr.2019.04.004","volume":"1","author":"KJ Schwenger","year":"2019","unstructured":"Schwenger KJ, Clermont-Dejean N, Allard JP (2019) The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 1(3):214\u2013226","journal-title":"JHEP Rep"},{"issue":"6052","key":"4992_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105\u2013108","journal-title":"Science"},{"key":"4992_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fimmu.2016.00054","volume":"7","author":"A Ignacio","year":"2016","unstructured":"Ignacio A, Morales CI, C\u00e2mara NO, Almeida RR (2016) Innate sensing of the gut microbiota: modulation of inflammatory and autoimmune diseases. Front Immunol 7:54","journal-title":"Front Immunol"},{"key":"4992_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2013.07.001","volume":"46","author":"J Henao-Mejia","year":"2013","unstructured":"Henao-Mejia J et al (2013) Role of the intestinal microbiome in liver disease. J Autoimmun 46:66\u201373","journal-title":"J Autoimmun"},{"issue":"2","key":"4992_CR16","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/j.1872-034X.2012.01088.x","volume":"43","author":"Y Miyake","year":"2013","unstructured":"Miyake Y, Yamamoto K (2013) Role of gut microbiota in liver diseases. Hepatol Res 43(2):139\u2013146","journal-title":"Hepatol Res"},{"issue":"6","key":"4992_CR17","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","volume":"140","author":"O Takeuchi","year":"2010","unstructured":"Takeuchi O, Akira S (2010) Pattern recognition receptors and inflammation. Cell 140(6):805\u2013820","journal-title":"Cell"},{"key":"4992_CR18","doi-asserted-by":"publisher","first-page":"240365","DOI":"10.1155\/2010\/240365","volume":"2010","author":"M Yamamoto","year":"2010","unstructured":"Yamamoto M, Takeda K (2010) Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010:240365","journal-title":"Gastroenterol Res Pract"},{"issue":"1","key":"4992_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.smim.2003.10.006","volume":"16","author":"C Pasare","year":"2004","unstructured":"Pasare C, Medzhitov R (2004) Toll-like receptors and acquired immunity. Semin Immunol 16(1):23\u201326","journal-title":"Semin Immunol"},{"issue":"5","key":"4992_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nri2515","volume":"9","author":"JL Round","year":"2009","unstructured":"Round JL, Mazmanian SK (2009) The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 9(5):313\u2013323","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"4992_CR21","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1073\/pnas.0904055107","volume":"107","author":"HK Kwon","year":"2010","unstructured":"Kwon HK et al (2010) Generation of regulatory dendritic cells and CD4\u2009+\u2009Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107(5):2159\u20132164","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"4992_CR22","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1073\/pnas.1211270110","volume":"110","author":"K Baruch","year":"2013","unstructured":"Baruch K et al (2013) CNS-specific immunity at the choroid plexus shifts toward destructive Th2 inflammation in brain aging. Proc Natl Acad Sci U S A 110(6):2264\u20132269","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"4992_CR23","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.molmed.2020.04.001","volume":"26","author":"X Zhang","year":"2020","unstructured":"Zhang X, Chen BD, Zhao LD, Li H (2020) The gut microbiota: emerging evidence in autoimmune diseases. Trends Mol Med 26(9):862\u2013873","journal-title":"Trends Mol Med"},{"issue":"12","key":"4992_CR24","doi-asserted-by":"publisher","first-page":"599","DOI":"10.3390\/fermentation10120599","volume":"10","author":"P Vinayamohan","year":"2024","unstructured":"Vinayamohan P, Joseph D, Viju LS, Baskaran SA, Venkitanarayanan K (2024) Efficacy of probiotics in reducing pathogenic potential of infectious agents. Fermentation 10(12):599","journal-title":"Fermentation"},{"key":"4992_CR25","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa Y et al (2013) Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504:446\u2013450","journal-title":"Nature"},{"key":"4992_CR26","doi-asserted-by":"publisher","first-page":"e01202","DOI":"10.7554\/eLife.01202","volume":"2","author":"JU Scher","year":"2013","unstructured":"Scher JU et al (2013) Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife 2:e01202","journal-title":"Elife"},{"key":"4992_CR27","doi-asserted-by":"publisher","first-page":"111282","DOI":"10.1016\/j.nut.2021.111282","volume":"89","author":"LAT Cannarella","year":"2021","unstructured":"Cannarella LAT et al (2021) Mixture of probiotics reduces inflammatory biomarkers and improves the oxidative\/nitrosative profile in people with rheumatoid arthritis. Nutrition 89:111282","journal-title":"Nutrition"},{"issue":"9","key":"4992_CR28","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/1756-185X.12888","volume":"19","author":"B Zamani","year":"2016","unstructured":"Zamani B et al (2016) Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int J Rheum Dis 19(9):869\u2013879","journal-title":"Int J Rheum Dis"},{"key":"4992_CR29","doi-asserted-by":"publisher","first-page":"12015","DOI":"10.1038\/ncomms12015","volume":"7","author":"S Jangi","year":"2016","unstructured":"Jangi S et al (2016) Alterations of the human gut microbiome in multiple sclerosis. Nat Commun 7:12015","journal-title":"Nat Commun"},{"issue":"1","key":"4992_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1001\/jamapediatrics.2015.2757","volume":"170","author":"U Uusitalo","year":"2016","unstructured":"Uusitalo U et al (2016) Association of early exposure of probiotics and islet autoimmunity in the TEDDY Study. JAMA Pediatr 170(1):20\u201328","journal-title":"JAMA Pediatr"},{"key":"4992_CR31","doi-asserted-by":"publisher","first-page":"18017","DOI":"10.1038\/nrdp.2018.17","volume":"4","author":"G Mieli-Vergani","year":"2018","unstructured":"Mieli-Vergani G et al (2018) Autoimmune hepatitis. Nat Rev Dis Primers 4:18017","journal-title":"Nat Rev Dis Primers"},{"key":"4992_CR32","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1146\/annurev-pathol-020117-043534","volume":"13","author":"GJ Webb","year":"2018","unstructured":"Webb GJ, Hirschfield GM, Krawitt EL, Gershwin ME (2018) Cellular and molecular mechanisms of autoimmune hepatitis. Annu Rev Pathol 13:247\u2013292","journal-title":"Annu Rev Pathol"},{"issue":"6","key":"4992_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/MCG.0000000000000805","volume":"51","author":"N Sonthalia","year":"2017","unstructured":"Sonthalia N et al (2017) Natural history and treatment outcomes of severe autoimmune hepatitis. J Clin Gastroenterol 51(6):548\u2013556","journal-title":"J Clin Gastroenterol"},{"key":"4992_CR34","doi-asserted-by":"publisher","first-page":"108863","DOI":"10.1016\/j.jnutbio.2021.108863","volume":"98","author":"Q Liu","year":"2021","unstructured":"Liu Q et al (2021) Probiotics alleviate autoimmune hepatitis in mice through modulation of gut microbiota and intestinal permeability. J Nutr Biochem 98:108863","journal-title":"J Nutr Biochem"},{"issue":"5","key":"4992_CR35","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/hep.27998","volume":"62","author":"M Yuksel","year":"2015","unstructured":"Yuksel M et al (2015) A novel humanized mouse model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology 62(5):1536\u20131550","journal-title":"Hepatology"},{"issue":"1","key":"4992_CR36","first-page":"85","volume":"57","author":"Y Mori","year":"1984","unstructured":"Mori Y et al (1984) Study of cellular immunity in experimental autoimmune hepatitis in mice. Clin Exp Immunol 57(1):85\u201392","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"4992_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/hep.1840110106","volume":"11","author":"AW Lohse","year":"1990","unstructured":"Lohse AW et al (1990) Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology 11(1):24\u201330","journal-title":"Hepatology"},{"key":"4992_CR38","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.nutres.2019.07.001","volume":"69","author":"YH Chen","year":"2019","unstructured":"Chen YH et al (2019) Gnotobiotic mice inoculated with Firmicutes, but not Bacteroidetes, deteriorate nonalcoholic fatty liver disease severity by modulating hepatic lipid metabolism. Nutr Res 69:20\u201329","journal-title":"Nutr Res"},{"issue":"5","key":"4992_CR39","first-page":"5153","volume":"8","author":"R Lin","year":"2015","unstructured":"Lin R, Zhou L, Zhang J, Wang B (2015) Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int J Clin Exp Pathol 8(5):5153\u20135160","journal-title":"Int J Clin Exp Pathol"},{"key":"4992_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fendo.2020.00125","volume":"11","author":"H Zhou","year":"2020","unstructured":"Zhou H et al (2020) Evaluating the causal role of gut microbiota in type 1 diabetes and its possible pathogenic mechanisms. Front Endocrinol (Lausanne) 11:125","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"4992_CR41","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.2337\/dc21-2225","volume":"45","author":"JIP van Heck","year":"2022","unstructured":"van Heck JIP et al (2022) The gut microbiome composition is altered in long-standing type 1 diabetes and associates with glycemic control and disease-related complications. Diabetes Care 45(9):2084\u20132094","journal-title":"Diabetes Care"},{"key":"4992_CR42","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00125-014-3274-0","volume":"57","author":"MC de Goffau","year":"2014","unstructured":"de Goffau MC et al (2014) Aberrant gut microbiota composition at the onset of type 1 diabetes in young children. Diabetology 57:1569\u20131577","journal-title":"Diabetology"},{"key":"4992_CR43","doi-asserted-by":"publisher","first-page":"e25792","DOI":"10.1371\/journal.pone.0025792","volume":"6","author":"Brown","year":"2011","unstructured":"Brown et al (2011) Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE 6:e25792","journal-title":"PLoS ONE"},{"key":"4992_CR44","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3345\/kjp.2018.61.7.217","volume":"61","author":"S Gursoy","year":"2018","unstructured":"Gursoy S, Kockar T, Atik SU, Onal Z, Onal H, Adal E (2018) Autoimmunity and intestinal colonization by Candida albicans in patients with type 1 diabetes at the time of the diagnosis. Korean J Pediatr 61:217\u2013220. https:\/\/doi.org\/10.3345\/kjp.2018.61.7.217","journal-title":"Korean J Pediatr"},{"key":"4992_CR45","doi-asserted-by":"publisher","first-page":"e0125448","DOI":"10.1371\/journal.pone.0125448","volume":"10","author":"S Candon","year":"2015","unstructured":"Candon S et al (2015) Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes. PLoS ONE 10:e0125448","journal-title":"PLoS ONE"},{"key":"4992_CR46","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s00125-012-2564-7","volume":"55","author":"CHF Hansen","year":"2012","unstructured":"Hansen CHF et al (2012) Early life treatment with vancomycin propagates Akkermansia muciniphila and reduces diabetes incidence in the NOD mouse. Diabetology 55:2285\u20132294","journal-title":"Diabetology"},{"key":"4992_CR47","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00125-005-1831-2","volume":"48","author":"F Calcinaro","year":"2005","unstructured":"Calcinaro F et al (2005) Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse. Diabetology 48:1565\u20131575","journal-title":"Diabetology"},{"key":"4992_CR48","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.3389\/fimmu.2017.01345","volume":"8","author":"L Jia","year":"2017","unstructured":"Jia L et al (2017) Clostridium butyricum CGMCC0313.1 protects against autoimmune diabetes by modulating intestinal immune homeostasis and inducing pancreatic regulatory T cells. Front Immunol 8:1345","journal-title":"Front Immunol"},{"key":"4992_CR49","doi-asserted-by":"publisher","first-page":"e10507","DOI":"10.1371\/journal.pone.0010507","volume":"5","author":"R Valladares","year":"2010","unstructured":"Valladares R et al (2010) Lactobacillus johnsonii N6.2 mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE 5:e10507","journal-title":"PLoS ONE"},{"key":"4992_CR50","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jaut.2014.03.005","volume":"53","author":"J Peng","year":"2014","unstructured":"Peng J (2014) Long term effect of gut microbiota transfer on diabetes development. J Autoimmun 53:85\u201394","journal-title":"J Autoimmun"},{"key":"4992_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/ismej.2015.114","volume":"10","author":"K Brown","year":"2015","unstructured":"Brown K et al (2015) Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. ISME J 10:321","journal-title":"ISME J"},{"key":"4992_CR52","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.2337\/db12-0526","volume":"62","author":"MC de Goffau","year":"2013","unstructured":"de Goffau MC et al (2013) Fecal microbiota composition differs between children with beta-cell autoimmunity and those without. Diabetes 62:1238\u20131244","journal-title":"Diabetes"},{"key":"4992_CR53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.chom.2015.01.001","volume":"17","author":"AD Kostic","year":"2015","unstructured":"Kostic AD, Gevers D, Siljander H, Vatanen T, Hyotylainen T, Hamalainen AM et al (2015) The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17:260\u2013273. https:\/\/doi.org\/10.1016\/j.chom.2015.01.001","journal-title":"Cell Host Microbe"},{"key":"4992_CR54","doi-asserted-by":"publisher","first-page":"4169","DOI":"10.1038\/s41467-018-06473-x","volume":"9","author":"NT Ho","year":"2018","unstructured":"Ho NT et al (2018) Meta-analysis of effects of exclusive breastfeeding on infant gut microbiota across populations. Nat Commun 9:4169","journal-title":"Nat Commun"},{"issue":"1","key":"4992_CR55","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00125-020-05295-1","volume":"64","author":"PM Bock","year":"2021","unstructured":"Bock PM et al (2021) The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis. Diabetology 64(1):26\u201341","journal-title":"Diabetology"},{"key":"4992_CR56","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/DMSO.S238867","volume":"13","author":"A Zare Javid","year":"2020","unstructured":"Zare Javid A, Aminzadeh M, Haghighi-Zadeh MH, Jamalvandi M (2020) The effects of synbiotic supplementation on glycemic status, lipid profile, and biomarkers of oxidative stress in type 1 diabetic patients. A placebo-controlled, double-blind, randomized clinical trial. Diabetes Metab Syndr Obes 13:607\u2013617","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"3","key":"4992_CR57","doi-asserted-by":"publisher","first-page":"128","DOI":"10.5114\/pedm.2023.132025","volume":"29","author":"H Shabani-Mirzaee","year":"2023","unstructured":"Shabani-Mirzaee H et al (2023) The effect of oral probiotics on glycated haemoglobin levels in children with type 1 diabetes mellitus - a randomized clinical trial. Pediatr Endocrinol Diabetes Metab 29(3):128\u2013133","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"issue":"7216","key":"4992_CR58","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/nature07336","volume":"455","author":"L Wen","year":"2008","unstructured":"Wen L et al (2008) Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455(7216):1109\u20131113","journal-title":"Nature"},{"key":"4992_CR59","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jaut.2018.06.003","volume":"93","author":"E Gulden","year":"2018","unstructured":"Gulden E et al (2018) TRIF deficiency protects non-obese diabetic mice from type 1 diabetes by modulating the gut microbiota and dendritic cells. J Autoimmun 93:57\u201365","journal-title":"J Autoimmun"},{"key":"4992_CR60","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0021-9258(17)49908-X","volume":"295","author":"MC Simon","year":"2020","unstructured":"Simon MC et al (2020) Distinct alterations of gut morphology and microbiota characterize accelerated diabetes onset in non-obese diabetic mice. J Biol Chem 295:969\u2013980","journal-title":"J Biol Chem"},{"key":"4992_CR61","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1084\/jem.20150744","volume":"213","author":"FR Costa","year":"2016","unstructured":"Costa FR, Francozo MC, de Oliveira GG, Ignacio A, Castoldi A, Zamboni DS et al (2016) Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset. J Exp Med 213:1223\u20131239. https:\/\/doi.org\/10.1084\/jem.20150744","journal-title":"J Exp Med"},{"key":"4992_CR62","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cell.2005.05.007","volume":"122","author":"SK Mazmanian","year":"2005","unstructured":"Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL (2005) An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 122:107\u2013118","journal-title":"Cell"},{"key":"4992_CR63","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1101\/sqb.2013.78.020081","volume":"78","author":"RS Longman","year":"2013","unstructured":"Longman RS et al (2013) Microbiota: host interactions in mucosal homeostasis and systemic autoimmunity. Cold Spring Harb Symp Quant Biol 78:193\u2013201","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"2","key":"4992_CR64","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.immuni.2013.08.013","volume":"39","author":"L Yurkovetskiy","year":"2013","unstructured":"Yurkovetskiy L et al (2013) Gender bias in autoimmunity is influenced by microbiota. Immunity 39(2):400\u2013412","journal-title":"Immunity"},{"key":"4992_CR65","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaut.2015.08.019","volume":"66","author":"JA Pearson","year":"2016","unstructured":"Pearson JA, Wong FS, Wen L (2016) The importance of the non obese diabetic (NOD) mouse model in autoimmune diabetes. J Autoimmun 66:76\u201388","journal-title":"J Autoimmun"},{"key":"4992_CR66","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/ni.3854","volume":"18","author":"O Rouxel","year":"2017","unstructured":"Rouxel O et al (2017) Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol 18:1321\u20131331","journal-title":"Nat Immunol"},{"key":"4992_CR67","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3389\/fimmu.2018.01752","volume":"9","author":"L De Giorgi","year":"2018","unstructured":"De Giorgi L (2018) Increased iNKT17 cell frequency in the intestine of non-obese diabetic mice correlates with high bacterioidales and low clostridiales abundance. Front Immunol 9:1752","journal-title":"Front Immunol"},{"key":"4992_CR68","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.coi.2013.09.012","volume":"25","author":"S Zeissig","year":"2013","unstructured":"Zeissig S, Blumberg RS (2013) Commensal microbiota and NKT cells in the control of inflammatory diseases at mucosal surfaces. Curr Opin Immunol 25:690\u2013696","journal-title":"Curr Opin Immunol"},{"issue":"13 Suppl","key":"4992_CR69","first-page":"S295","volume":"18","author":"A Gibofsky","year":"2012","unstructured":"Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18(13 Suppl):S295\u2013302","journal-title":"Am J Manag Care"},{"key":"4992_CR70","doi-asserted-by":"publisher","first-page":"113074","DOI":"10.1016\/j.biopha.2022.113074","volume":"150","author":"Z Zhao","year":"2022","unstructured":"Zhao Z (2022) Application and pharmacological mechanism of methotrexate in rheumatoid arthritis. Biomed Pharmacother 150:113074","journal-title":"Biomed Pharmacother"},{"key":"4992_CR71","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/978-1-59745-541-1_20","volume":"517","author":"F Brentano","year":"2009","unstructured":"Brentano F, Kyburz D, Gay S (2009) Toll-like receptors and rheumatoid arthritis. Methods Mol Biol 517:329\u2013343 https:\/\/doi.org\/10.1007\/978-1-59745-541-1_20","journal-title":"Methods Mol Biol"},{"issue":"2","key":"4992_CR72","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ccr3.3677","volume":"9","author":"J Zeng","year":"2020","unstructured":"Zeng J (2020) Fecal microbiota transplantation for rheumatoid arthritis: a case report. Clin Case Rep 9(2):906\u2013909","journal-title":"Clin Case Rep"},{"key":"4992_CR73","doi-asserted-by":"publisher","first-page":"1211271","DOI":"10.3389\/fmicb.2023.1211271","volume":"14","author":"C Huang","year":"2023","unstructured":"Huang C (2023) Probiotics for the treatment of ulcerative colitis: a review of experimental research from 2018 to 2022. Front Microbiol 14:1211271","journal-title":"Front Microbiol"},{"issue":"1","key":"4992_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2010.04143.x","volume":"162","author":"JM Fletcher","year":"2010","unstructured":"Fletcher JM et al (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162(1):1\u201311","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"4992_CR75","first-page":"S2","volume":"74","author":"LH Kasper","year":"2010","unstructured":"Kasper LH, Shoemaker J (2010) Multiple sclerosis immunology: the healthy immune system vs the MS immune system. Neurology 74(Suppl 1):S2\u20138","journal-title":"Neurology"},{"issue":"37","key":"4992_CR76","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.3748\/wjg.v24.i37.4217","volume":"24","author":"CR Camara-Lemarroy","year":"2018","unstructured":"Camara-Lemarroy CR, Metz L, Yong VW (2018) Focus on the gut-brain axis: multiple sclerosis, the intestinal barrier and the microbiome. World J Gastroenterol 24(37):4217\u20134223","journal-title":"World J Gastroenterol"},{"key":"4992_CR77","doi-asserted-by":"publisher","first-page":"604179","DOI":"10.3389\/fimmu.2020.604179","volume":"11","author":"A Rutsch","year":"2020","unstructured":"Rutsch A, Kantsj\u00f6 JB, Ronchi F (2020) The gut-brain axis: how microbiota and host inflammasome influence brain physiology and pathology. Front Immunol 11:604179","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"4992_CR78","first-page":"64","volume":"233","author":"K Takata","year":"2011","unstructured":"Takata K (2011) Lactobacillus pentosus strain S-PT84 induces IL-10 production and suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol 233(1\u20132):64\u201372","journal-title":"J Neuroimmunol"},{"issue":"1","key":"4992_CR79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12934-017-0691-z","volume":"16","author":"JG LeBlanc","year":"2017","unstructured":"LeBlanc JG et al (2017) Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria. Microb Cell Factories 16(1):79","journal-title":"Microb Cell Factories"},{"issue":"11","key":"4992_CR80","first-page":"61","volume":"20","author":"TL Montgomery","year":"2020","unstructured":"Montgomery TL, Kuffler DP, Brown MA (2020) Dysbiosis and the gut-brain axis in multiple sclerosis: interactions between diet, gut microbiota, and the immune system. Curr Allergy Asthma Rep 20(11):61","journal-title":"Curr Allergy Asthma Rep"},{"issue":"4","key":"4992_CR81","first-page":"749","volume":"25","author":"M Rahimlou","year":"2022","unstructured":"Rahimlou M et al (2022) Probiotic supplementation attenuates inflammation and modulates gut microbiota in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Nutr Neurosci 25(4):749\u2013759","journal-title":"Nutr Neurosci"},{"issue":"5","key":"4992_CR82","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.clnu.2016.08.015","volume":"36","author":"E Kouchaki","year":"2017","unstructured":"Kouchaki E et al (2017) Clinical and metabolic response to probiotic administration in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. Clin Nutr 36(5):1245\u20131249","journal-title":"Clin Nutr"},{"key":"4992_CR83","first-page":"105484","volume":"102","author":"M Aghamohammadi","year":"2023","unstructured":"Aghamohammadi M et al (2023) The effects of Saccharomyces boulardii supplementation on clinical and metabolic parameters in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial. J Function Foods 102:105484","journal-title":"J Function Foods"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04992-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-026-04992-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-026-04992-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T15:03:05Z","timestamp":1782745385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-026-04992-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["4992"],"URL":"https:\/\/doi.org\/10.1007\/s00284-026-04992-1","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"20 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"391"}}